Insider Buying: Cosmos Health Inc. (NASDAQ:COSM) CEO Buys $198,405.76 in Stock

Posted by Joseph Casey on Feb 28th, 2025

Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas acquired 354,296 shares of the company’s stock in a transaction on Monday, February 24th. The shares were bought at an average cost of $0.56 per share, with a total value of $198,405.76. Following the acquisition, the chief executive officer now directly owns 3,897,016 shares in the company, valued at approximately $2,182,328.96. The trade was a 10.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Grigorios Siokas also recently made the following trade(s):

On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The stock was purchased at an average price of $0.66 per share, for a total transaction of $33,933.24.
On Wednesday, January 22nd, Grigorios Siokas purchased 38,900 shares of Cosmos Health stock. The shares were purchased at an average price of $0.77 per share, with a total value of $29,953.00.
On Friday, January 17th, Grigorios Siokas acquired 29,158 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.86 per share, for a total transaction of $25,075.88.
On Wednesday, January 15th, Grigorios Siokas bought 62,500 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $50,000.00.
On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $99,836.26.
On Friday, December 20th, Grigorios Siokas acquired 257,334 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.58 per share, with a total value of $149,253.72.

Cosmos Health Stock Down 4.6 %

Shares of NASDAQ:COSM opened at $0.54 on Friday. The company has a market cap of $12.54 million, a price-to-earnings ratio of -0.22 and a beta of 5.56. Cosmos Health Inc. has a 12 month low of $0.47 and a 12 month high of $1.58. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The company has a 50-day moving average price of $0.69 and a 200 day moving average price of $0.81.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC increased its stake in shares of Cosmos Health Inc. (NASDAQ:COSM – Free Report) by 29.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 at the end of the most recent quarter. 12.61% of the stock is owned by hedge funds and other institutional investors.

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.